Publication:
Pesg PNH diagnosis, follow-up and treatment guidelines

dc.contributor.coauthorŞahin, Fahri
dc.contributor.coauthorAyer, Mesut
dc.contributor.coauthorDal, Mehmet Sinan
dc.contributor.coauthorErtop, Şehmus
dc.contributor.coauthorİlhan, Osman
dc.contributor.coauthorKarakuş, Volkan
dc.contributor.coauthorÖzcan, Mehmet Ali
dc.contributor.coauthorÖzkocaman, Vildan
dc.contributor.coauthorÖzsan, Hayri
dc.contributor.coauthorSalim, Ozan
dc.contributor.coauthorTobu, Mahmut
dc.contributor.coauthorTombak, Anıl
dc.contributor.coauthorTuğlular, Tülin Fıratlı
dc.contributor.coauthorYılmaz, Mehmet
dc.contributor.coauthorÜnal, Ali
dc.contributor.coauthorYenerel, Mustafa Nuri
dc.contributor.coauthorSaydam, Güray
dc.contributor.kuauthorAkay, Olga Meltem
dc.contributor.kuprofileFaculty Member
dc.contributor.unitKoç University Hospital
dc.contributor.yokid170966
dc.date.accessioned2024-11-09T11:56:58Z
dc.date.issued2016
dc.description.abstractPNH Education and Study Group (PESG) have been established in December 2013 as a non-profit, independent, medical organization www.pesg.org. Paroxysmal Nocturnal Hemoglobinuria (PNH) is a multi-systemic disease that should be treated with a multidisciplinary approach. Patients may apply to the clinics other than the hematology due to variability and diversity of clinical findings which lower the rate of diagnosis due to low awareness about PNH. PNH might be overlooked and diagnosis might be delayed. Regarding these, PESG was established with the collaboration of Immunology, Cardiology, Thorax Diseases (Pulmonology), Neurology, Gastroenterology, General Surgery and Urology specialists in addition to hematologists dealing with PNH. The PESG study group aims to increase the awareness about PNH, including training activities about PNH, strengthening the relations between clinics and planning of clinical studies as a goal. It is the first professional organization focusing on PNH, in Turkey.In this guideline, we want to facilitate the diagnosis attributes of physicians from all specializations that deal with PNH and its systemic complications. One can perceive this as a tailor made guideline of international guidelines but not a compilation.
dc.description.fulltextYES
dc.description.indexedbyWoS
dc.description.indexedbyScopus
dc.description.indexedbyPubMed
dc.description.issue2
dc.description.openaccessYES
dc.description.publisherscopeInternational
dc.description.sponsoredbyTubitakEuN/A
dc.description.sponsorshipN/A
dc.description.versionPublisher version
dc.description.volume6
dc.formatpdf
dc.identifier.embargoNO
dc.identifier.filenameinventorynoIR00673
dc.identifier.issn2160-1992
dc.identifier.quartileN/A
dc.identifier.urihttps://hdl.handle.net/20.500.14288/863
dc.identifier.wos388367600001
dc.keywordsPNH
dc.keywordsGuideline
dc.keywordsDiagnosis
dc.keywordsTreatment
dc.languageEnglish
dc.publishere-Century Publishing Corporation
dc.relation.urihttp://cdm21054.contentdm.oclc.org/cdm/ref/collection/IR/id/540
dc.sourceAmerican Journal of Blood Research
dc.subjectResearch and experimental medicine
dc.subjectHematology
dc.titlePesg PNH diagnosis, follow-up and treatment guidelines
dc.typeReview
dspace.entity.typePublication
local.contributor.authorid0000-0002-6759-1939
local.contributor.kuauthorAkay, Olga Meltem

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
540.pdf
Size:
469.13 KB
Format:
Adobe Portable Document Format